Assessment of the role of GM-CSF in the cellular transformation and the development of erosive lesions around orthopaedic implants

American Journal of Clinical Pathology

Volumn 105, Issue 5, 1996, Pages 628-639

  Al Saffar, Najat ^a   Khwaja, Haris A ^a   Kadoya, Yoshinori ^a   Revell, Peter A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cytokines; Giant cells; GM CSF; Orthopaedic implants; Osteolysis

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL TRANSFORMATION; CLINICAL ARTICLE; CLINICAL FEATURE; COXITIS; FEMALE; HISTOLOGY; HUMAN; IMPLANT; KNEE OSTEOARTHRITIS; MACROPHAGE ACTIVATION; MALE; PRIORITY JOURNAL; PROSTHESIS LOOSENING; RHEUMATOID ARTHRITIS; TISSUE DISTRIBUTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

EID: 0029878554     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.5.628     Document Type: Article

References (67)

1. Brown IW, Ring PA. Osteolytic changes in the upper femoral shaft following porous-coated hip replacement. J Bone Joint Surg 1985;67[B]:218-221.
2. Maloney WJ, Jasty MJ, Rosenberg A, Harris WH. Bone lysis in well-fixed cemented femoral components. J Bone Joint Surg 1990;72[B]:966-970.
3. Pierson JL, Harris WH. Extensive osteolysis behind an acetabular component that was well fixed with cement. J Bone Joint Surg 1993;75[A]:268-271.
4. Revell PA. Tissue reaction to joint prostheses and the products of wear and corrosion. In: Berry CL, ed. Bone and Joint Disease. Berlin: Springer-Verlag, 1982, pp 73-101.
5. Goldring SR, Schiller AL, Roelke M, Rourke CM, O'Neill DA, Harris WH. The synovial like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg 1983;65[A]:575-584.
6. Agins HJ, Alcock NW, Bansal M, et al. Metallic wear in failed titanium-alloy total hip replacements: A histological and quantitative analysis. J Bone Joint Surg 1988;70[A]:347-356.
7. Pazzaglia UE, Byers PD. Fractured femoral shaft through an osteolytic lesion resulting from the reaction to a prosthesis: A case report. J Bone Joint Surg 1984;66[B]:337-339.
8. Howie DW, Haynes DR, Rogers SD, McGee MA, Pearcy MJ. The response to paniculate debris. Orthop Clin North Am 1993;24: 571-581.
9. Whitehall R, Drucker S, McCoig JA, et al. Induction and characterization of an interface tissue by implantation of methylmethacrylate cement into the posterion part of the cervical spine of the dog. J Bone Joint Surg 1998;70[A]:51-59.
10. Goldring SR, Wojno WC, Schiller AL, Scott RD. In patients with rheumatoid arthritis the tissue reaction associated with loosened total knee replacements exhibits features of rheumatoid synovium. J Orthop Rheumatol 1988;1:9-21.
11. Tallroth K, Eskola A, Santavirta S, Konttinen YT, Lindholm TS. Aggressive granulomatous lesions after hip arthroplasty. J Bone Joint Surg 1989;71[B]:571-575.
12. Santavirta S, Konttinen YT, Bergroth V, Eskola A, Tallroth K, Lindholm TS. Aggressive granulomatous lesions in hip arthroplasty: Immunopathological studies. J Bone Joint Surg 1990;72[A]:252-258.
13. Thomson BM, Saklatvala J, Chambers TJ. Osteoblasts mediate interleukin I stimulation of bone resorption by rat osteoclasts. J Exp Med 1986;164:104-112.
14. Thomson BM, Mundy GR, Chambers TJ. Tumour necrosis factors a and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987;138:775-779.
15. Vaes G. Cellular biology and biochemical mechanism of bone resorption: A review of recent development on the formation, activation and mode of action of osteoclasts. Clin Orthop 1988;231:239-271.
16. Zallone ZA, Teli A, Primavera MV. Monocytes from circulating blood fuse in vitro with purified osteoclasts in primary culture. J Cell Sci 1984;66:335-342.
17. Roodman GD, Ibbotson KJ, MacDonald BR, Kuehl TJ, Mundy GR. 1,25(OH)2 vitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow. Proc Natl Acad Sci USA 1985;82:8213-8217.
18. Fuller K, Chambers TJ. Generation of osteoclasts in culture of rabbit bone marrow and spleen cells. J Cell Physiol 1987;132:441-452.
19. Takahashi N, Yamana H, Roodman D, et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 1988;122:1373-1382.
20. Ibbotson KJ, Roodman GD, McManus LM, Mundy GR. Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells. J Cell Biol 1984;99:471-474.
21. Ash P, Loutil JF, Townsend KMF. Osteoclasts derived from haemopoietic stem cells. Nature 1980;283:669-670.
22. Coccia PF, Krivit W, Cervenka J, et al. Successful bone marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 1980;302:701-708.
23. Khan AJ, Simmons DJ. Investigation of cell lineage in bone using chimera of chicks and quail embryonic tissue. Nature 1975;258: 325-327.
24. Walker DG. Bone resorption restored in osteopetrotic mice by transplant of normal bone marrow and spleen cells. Science 1975;190:784-785.
25. Scheven BAA, Visser JWM, Nijweide PJ. In vitro osteoclast generation from different bone marrow fractions including a highly enriched haematopoietic stem cell population. Nature 1986;321:79-81.
26. Emerson SG, Sieff CA, Wang EA, Wong GG, Clark SC, Nathan DG. Purification of fetal hematopoeitic progenitors and demonstration of recombinant multipotential colony stimulating activity. J Clin Invest 1985;76:1286-1290.
27. Metcalf D, Begley CG, Johnson GR, et al. Biological properties in vitro of a recombinant human granulocyte-macrophage colony stimulating factor. Blood 1986;67:37-45.
28. Ikebuchi K, Clark SC, Ihle JN, Souza LM, Ogawa M. Granulocyte colony stimulating factor enhances interleukin 3 dependent proliferation of multipotential haematopoietic progenitors. Proc Natl Acad Sci USA 1988;85:3445-3449.
29. MacDonald BR, Mundy GR, Clark S, Wang EA, Kuehl TJ, Stanley E R, Roodman GD. Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J Bone Miner Res 1986;1:227-233.
30. Lorenzo JA, Sousa SL, Fonseca JM, Hock JM, Medlock ES. Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro. J Clin Invest 1987;80:160-164.
31. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Shiopnome M, Suda T. Role of colony stimulating factors in osteoclast development. J Bone Miner Res 1991;6:977-985.
32. Thorens B, Mermod JJ, Vassali P. Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscription regulation. Cell 1987;48:671-679.
33. Munker R, Gasson HJ, Ogawa M, Koeffler HP. Recombinant human tumour necrosis factor induces production of granulocyte-monocyte colony stimulating factors mRNA and protein from lung fibroblasts and vascular endothelial cells in vivo. Nature 1986;323:79-82.
34. Zucali JR, Dinarello CA, Oblon DJ, Gross MA, Anderson L, Weiner RS. Interleukin-1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest 1986;77:1857-1863.
35. Seelentag WK, Mermond JJ, Montesano R, Vassalli P. Additive effects of interleukin-1 and tumour necrosis factor alpha on the accumulation of the three granulocyte and macrophage colony stimulating factor mRNAs in human endothelial cells. EMBO J 1987;6:2261-2265.
36. Horowitz MC, Coleman DL, Flood PM, Kupper TS, Jilka R. Parathyroid hormone and lipopolysaccharide induce murine osteoblast-like cells to secrete a cytokine indistinguishable from granulocyte-macrophage colony stimulating factor. J Clin Invest 1989;83:149-157.
37. Koeffler HP, Gasson J, Raynywad J, et al. Recombinant human TNF alpha stimulates the production of granulocyte-macrophage colony stimulating factor. Blood 1987;70:55-59.
38. Firestein GS, Zvaifler NJ. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid tissue interferon suggest that gamma interferon is not the primary macrophage activating factor. Arthritis Rheum 1987;30:864-871.
39. AL Saffar N, Revell PA. Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: A potential role in osteolysis. Br J Rheumatol 1994;33:309-316.
40. Moqbel R, Hamid K, Ying S, et al. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 1991;174:749-752.
41. Chen BDM, Clark CR, Chou TH. Granulocyte-macrophage colony stimulating factor stimulates monocyte and tissue macrophage proliferation and enhances their responsiveness to macrophage colony stimulating factor. Blood 1988;71:997-1002.
42. Morrissey PJ, Bressler L, Charrier K, Alpert A. Response of resident murine peritoneal macrophages to in vivo administration of granulocyte-macrophage colony-stimulating factor. J Immunol 1988;140:1910-1915.
43. Nakata K, Akagawa K, Fukayama M, Hayashi Y, Kadokura M, Tokunaga T. Granulocyte-macrophage colony stimulating factor promotes the proliferation of alveolar macrophages in vitro. J Immunol 1991;147:1266-1272.
44. Pharoah MJ, Heersche JNM. 1,25-dihydroxyvitamin D3 causes an increase in the number of osteoclast like cells in cat bone marrow cultures. Calcif Tissue Int 1985;37:276-281.
45. Shinar DM, Sato M, Rodan GA. The effect of haemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow culture. Endocrinology 1991;126:1728-1735.
46. Kondo Y, Sato K, Ohkawa H, et al. Association of hypercalcemia with tumours producing colony stimulating factors. Cancer Res 1983;43:2368-2374.
47. Wiktor-Jedrzejzcak W, Ahmed A, Szczylik C, Skelly RR. Hematological characterization of congenital osteopetrosis in op/op mouse. J Exp Med 1982;156:1516-1527.
48. Edwards JC, Willoughby DA. Demonstration of bone marrow derived in synovial lining by means of giant intracellular granules as genetic markers. Ann Rheum Dis 1982;41:177-182.
49. AL Saffar N, Mah JTL, Kadoya Y, Revell PA. Neovascularization and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants. Ann Rheum Dis 1995;54:201-208.
50. Levack B, Revell PA, Freeman MAR. Presence of macrophages at the bone-cement interface of stable hip arthroplasty components. Acta Orthop Scand 1987;58:384-387.
51. Voigt C, Merle C, Muller-Mai C, Gross U. Substitution of natural coral by cortical bone and bone marrow in the rat femur. Journal of Materials Science: Materials in Medicine 1994;5:688-691.
52. Lord BI, Testa NG, Hendry JH. The relative spatial distribution of CFU-S and CFU-C in the normal mouse femur. Blood 1975;46: 65-72.
53. Schaefer HE. Cytology and histopathology of the normal human bone marrow. In: Lennert K, Hubner K, eds. Pathology of the Bone Marrow. Stuttgart: Verlag, 1984, pp 33-53.
54. Thesingh CW, Burger EH. The role of mesenchyme in embryonic long bones as early deposition site for osteoclast cells. Dev Biol 1983;95:429-438.
55. Burger EH, Van Der Meer JWM, Van De Gevel JS, Gribnau JC, Thesingh CW, Van Furth R. In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med 1982;156:1604-1614.
56. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. IV Granulocyte/macrophage colony-stimulating factor mediated induction of class II MHC antigen on human monocytes: A possible role in rheumatoid arthritis. J Exp Med 1989;170:865-875.
57. Thorens B, Mermod JJ, Vassalli P. Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell 1987;48:671-679.
58. Dayer JM, Ricard-Blum S, Kaufmann MT, Herbage D. Type IX collagen is a potent inducer of PGE2 and interleukin-1 production by human monocyte macrophages. FEBS Lett 1986;198:208-212.
59. Scott DL, Wainwright AC, Walton KW, Williamson N. Significance of fibronectin in rheumatoid arthritis and osteoarthrosis. Ann Rheum Dis 1981;40:207-212.
60. Revell PA, Al Saffar N, Fish S, Osei D. The extracellular matrix of the synovial intimal cell layer. Ann Rheum Dis 1995;54:404-407
61. Gowen M, Mundy GR. Action of recombinant interleukin-1, interleukin-2 and interferon-gamma on bone resorption in vitro. J Immunol 1986;136:2478-2487.
62. Canalis E. Interleukin-1 has independent effect on deoxyribonucleic acid and collagen synthesis in cultures of rat calvaria. Endocrinology 1986;118:74-81.
63. Moore RN, Oppenheim JJ, Farrar JJ, Carter CS, Waheed A, Sadduck RK. Production of lymphocyte activating factor (IL-1) by macrophages activated with colony stimulating factors. J Immunol 1980;125:1302-1305.
64. Tsai V, Firestein GS, Arend W, Zvaifler NJ. Cytokine-induced differentiation of cultured nonadherent macrophages. Cell Immunol 1992;144:203-216.
65. Mardon HJ, Bee J, von der Mark K, Owen ME. Development of osteogenic tissue in diffusion chambers from early precursor cells in bone marrow of adult rats. Cell Tissue Res 1987;250: 157-165.
66. Diduch DR, Coe MR, Joyner C, Owen ME, Balian G. Two cell lines from bone marrow that differ in terms of collagen synthesis, osteogenic characteristics, and matrix mineralization. J Bone Joint Surg 1993;75[A]:92-105.
67. Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987;326:403-405.